.05 semaglutide (Month 1) 0.25mg π Why do we prefer
Description
doi: 10.2337/db12-0975
While there is limited evidence regarding tirzepatide use specifically in patients with significant thyroid disease (as these patients were typically excluded from pivotal trials), there is no established direct pharmacological interaction between tirzepatide and Graves disease pathophysiology

To further understand the connection between reproduction, longevity, and lipid metabolism, we selected three mutants, representing three different types of self-sterility, for detailed studies: the germline-less glp-1(e2144) , the feminized fem-3(e1996) and the masculinized mog-3(q74)

2005a;186:221231

doi: 10.2337/db14-0849
